companydata.dkcompanydata.dk

Nykode Therapeutics Denmark A/S: Financial statements 2024

CVR: 42038660

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Nykode Therapeutics Denmark A/S (CVR 42038660) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 63,552,511 and a net result of DKK 156,959 compared with DKK 2,484,505 the year before. That is an increase of 20.1% compared with the year before. Equity in the 2024 report amounted to DKK 5,514,972. The solvency ratio was 27%. The company had 31 employees in the financial year.

Gross Profit
DKK 63,552,511
Profit/Loss
DKK 156,959
Equity
DKK 5,514,972
Total Assets
DKK 20,422,248
Employees
31

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-63.6M157K5.5M31
2023-52.9M2.5M5.4M31
2022-38.6M1.9M2.9M23
2021-10.6M578K978K7

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Nykode Therapeutics Denmark A/S: The 2023 annual report is outJun 12, 2024

Nykode Therapeutics Denmark A/S has published its annual report for 2023. Gross profit came to DKK 52,927,648, and the net result was DKK 2,484,505.

About Nykode Therapeutics Denmark A/S

Nykode Therapeutics Denmark A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Vaccibody Denmark A/S. The management consists of Michael Thyrring Engsig. The board consists of Louise Stubbe (chair), Harald Gurvin and Michael Thyrring Engsig. The company is owned by Nykode Therapeutics ASA. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 31,839,001 and a net result of DKK 1,347,127 compared with DKK 156,959 the year before. Equity in the 2025 report amounted to DKK 6,862,099.

Source: annual report 2025, Danish Business Authority

Other financial years